References: 1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
2. Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache. 2011;51(suppl 2):77S-83S.
3. Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30(5):599·609.
4. Centers for Disease Control and Prevention. Census projections request. CDC WONDER website. http://wonder.cdc.gov/population-projections.html. Accessed December 11, 2018.
5. Dodick DW, Loder EW, Manack A. Assessing barriers to Chronic Migraine consultation, diagnosis, and treatment: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. [published online ahead of print May 3, 2016]. Headache. doi: 10.1111/head.12774.
6. Data on file, Allergan; Millward Brown Chronic Migraine Analysis.
7. Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the Second International Burden of Migraine Study (IBMS-II). Headache. 2013;53(4):644-655.
8. Aurora SK, Brin MF. Chronic Migraine: An update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies. Headache. 2017;57(1):109-125.
9. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754-762.
10. Kristoffersen ES, Lundqvist C. Medication-overuse headache: a review. J Pain Res. 2014;26(7):367-378.
11. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71(8):559-566.